{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:40:13Z","timestamp":1782981613943,"version":"3.54.5"},"reference-count":378,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P42 ES013661"],"award-info":[{"award-number":["P42 ES013661"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES035019"],"award-info":[{"award-number":["R01 ES035019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS119528"],"award-info":[{"award-number":["R01 NS119528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 ES005606"],"award-info":[{"award-number":["P30 ES005606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES025750"],"award-info":[{"award-number":["R01 ES025750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES029035"],"award-info":[{"award-number":["R01 ES029035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["ASAP-020607"],"award-info":[{"award-number":["ASAP-020607"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neuro.2024.06.016","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:13:11Z","timestamp":1719965591000},"page":"266-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology"],"prefix":"10.1016","volume":"103","author":[{"given":"Fatema","family":"Currim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeya","family":"Tanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Brown-Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Paranjape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2024.06.016_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxlet.2018.01.017","article-title":"Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure","volume":"287","author":"Agim","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg2268","article-title":"Genome instability: a mechanistic view of its causes and consequences","volume":"9","author":"Aguilera","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-022-00297-9","article-title":"Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages","volume":"8","author":"Ahmadi Rastegar","year":"2022","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jmp3040021","article-title":"The roles of calcium ions in Parkinson\u2019s disease: calcium channel inhibitors as a novel agents?","volume":"3","author":"Alam","year":"2022","journal-title":"J. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson\u2019s disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/tx300458b","article-title":"Cellular localization of dieldrin and structure\u2013activity relationship of dieldrin analogues in dopaminergic cells","volume":"26","author":"Allen","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"7598","key":"10.1016\/j.neuro.2024.06.016_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature17623","article-title":"Astrocyte scar formation aids central nervous system axon regeneration","volume":"532","author":"Anderson","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.chemrestox.5b00528","article-title":"Antioxidant-mediated modulation of protein reactivity for 3, 4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite","volume":"29","author":"Anderson","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"30","key":"10.1016\/j.neuro.2024.06.016_bib10","doi-asserted-by":"crossref","first-page":"26978","DOI":"10.1074\/jbc.M111.249532","article-title":"Oxidation of 3, 4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone","volume":"286","author":"Anderson","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s11356-013-1977-2","article-title":"Concentration levels and congener profiles of polychlorinated biphenyls, pentachlorobenzene, and hexachlorobenzene in commercial pigments","volume":"21","author":"Anezaki","year":"2014","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib12","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1242\/jcs.180737","article-title":"Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity","volume":"129","author":"Angelova","year":"2016","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/hmg\/ddz271","article-title":"G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice","volume":"29","author":"Arbez","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.201401070","article-title":"Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin","volume":"206","author":"Ashrafi","year":"2014","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/glia.440070117","article-title":"Cytotoxicity of microglia","volume":"7","author":"Banati","year":"1993","journal-title":"Glia"},{"issue":"14","key":"10.1016\/j.neuro.2024.06.016_bib16","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1021\/acs.est.0c08149","article-title":"Room-to-room variability of airborne polychlorinated biphenyls in schools and the application of air sampling for targeted source evaluation","volume":"55","author":"Bannavti","year":"2021","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0361-9230(83)90218-6","article-title":"Histochemical observations on rodent brain melanin","volume":"10","author":"Barden","year":"1983","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuro.2024.06.016_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.emcon.2018.12.004","article-title":"New\u2019 unintentionally produced PCBs in the Arctic","volume":"5","author":"Bartlett","year":"2019","journal-title":"Emerg. Contam."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","article-title":"Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits","volume":"114","author":"Beach","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.stemcr.2021.06.003","article-title":"Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells","volume":"16","author":"Bell","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0344-2","article-title":"LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same","volume":"14","author":"Berwick","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuro.2024.06.016_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","article-title":"LRRK2 modifies \u03b1-syn pathology and spread in mouse models and human neurons","volume":"137","author":"Bieri","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"30","key":"10.1016\/j.neuro.2024.06.016_bib24","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1021\/ja0618649","article-title":"Interaction of \u03b1-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement","volume":"128","author":"Binolfi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib25","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/brain\/awaa216","article-title":"Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease","volume":"143","author":"Biondetti","year":"2020","journal-title":"Brain"},{"issue":"21","key":"10.1016\/j.neuro.2024.06.016_bib26","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","article-title":"Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with \u03b1-synuclein","volume":"282","author":"Bisaglia","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"12","key":"10.1016\/j.neuro.2024.06.016_bib28","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: Why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/rej.2008.0716","article-title":"Carnisone increases efficiency of DOPA therapy of Parkinson\u2019s disease: a pilot study","volume":"11","author":"Boldyrev","year":"2008","journal-title":"Rejuvenation Res."},{"issue":"46","key":"10.1016\/j.neuro.2024.06.016_bib30","doi-asserted-by":"crossref","first-page":"eabb2454","DOI":"10.1126\/sciadv.abb2454","article-title":"LRRK2 mediates tubulation and vesicle sorting from lysosomes","volume":"6","author":"Bonet-Ponce","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1289\/ehp.1306532","article-title":"Polychlorinated biphenyl exposures and cognition in older U.S. adults: NHANES (1999\u20132002)","volume":"122","author":"Bouchard","year":"2014","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm2351","article-title":"Regulation of DNA repair throughout the cell cycle","volume":"9","author":"Branzei","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuro.2024.06.016_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2014.00152","article-title":"Molecular determinants of selective dopaminergic vulnerability in Parkinson\u2019s disease: an update","volume":"8","author":"Brichta","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuro.2024.06.016_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-0888-2_11","article-title":"The roles of cohesins in mitosis, meiosis, and human health and disease","author":"Brooker","year":"2014","journal-title":"Cell Cycle Control: Mech. Protoc."},{"issue":"13","key":"10.1016\/j.neuro.2024.06.016_bib37","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/acschemneuro.1c00096","article-title":"Intranasal carnosine mitigates \u03b1-synuclein pathology and motor dysfunction in the Thy1-aSyn mouse model of Parkinson\u2019s disease","volume":"12","author":"Brown","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib38","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1021\/acs.chemrestox.2c00072","article-title":"Neurotransmission targets of per- and polyfluoroalkyl substance neurotoxicity: mechanisms and potential implications for adverse neurological outcomes","volume":"35","author":"Brown-Leung","year":"2022","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41531-021-00161-2","article-title":"Dynamic control of the dopamine transporter in neurotransmission and homeostasis","volume":"7","author":"Bu","year":"2021","journal-title":"NPJ Park.\u2019s Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-020-00134-x","article-title":"Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson\u2019s disease","volume":"6","author":"Bucher","year":"2020","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"key":"10.1016\/j.neuro.2024.06.016_bib41","unstructured":"Bullert, A., Li, X., Lee, K., Pulliam, C.F., Cagle, B.S., Doorn, J.A., Klingelhutz, A.J., Robertson, L.W.,\u00a0Lehmler, H.-J., n.d. Disposition and Metabolomic Effects of 2,2\u2019,5,5\u2019-Tetrachlorobiphenyl in Female Rats Following Intraperitoneal Exposure."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0161-813X(03)00090-1","article-title":"Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases","volume":"25","author":"Burke","year":"2004","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib43","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0139-22.2022","article-title":"Axonal domain structure as a putative identifier of neuron-specific vulnerability to oxidative stress in cultured neurons","volume":"9","author":"Burke","year":"2022","journal-title":"Eneuro"},{"key":"10.1016\/j.neuro.2024.06.016_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.freeradbiomed.2017.03.030","article-title":"Oxidative DNA damage & repair: an introduction","volume":"107","author":"Cadet","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuro.2024.06.016_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cotox.2018.12.002","article-title":"Biogenic aldehyde-mediated mechanisms of toxicity in neurodegenerative disease","volume":"13","author":"Cagle","year":"2019","journal-title":"Curr. Opin. Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","article-title":"The role of environmental exposures in neurodegeneration and neurodegenerative diseases","volume":"124","author":"Cannon","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuro.2024.06.016_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.115148","article-title":"A systematic evidence map for the evaluation of noncancer health effects and exposures to polychlorinated biphenyl mixtures","volume":"220","author":"Carlson","year":"2023","journal-title":"Environ. Res."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/tx5002223","article-title":"Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson\u2019s disease","volume":"27","author":"Casida","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib51","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/febs.15908","article-title":"Interpreting the role of the striatum during multiple phases of motor learning","volume":"289","author":"Cataldi","year":"2022","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/toxsci\/kfl018","article-title":"Polychlorinated biphenyl\u2013induced reduction of dopamine transporter expression as a precursor to Parkinson\u2019s disease\u2013associated dopamine toxicity","volume":"92","author":"Caudle","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"30","key":"10.1016\/j.neuro.2024.06.016_bib53","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib54","article-title":"Cytoarchitectural changes in the olfactory bulb of Parkinson\u2019s disease patients","volume":"2","author":"Cave","year":"2016","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib55","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuro.2024.06.016_bib56","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00702-018-1887-z","article-title":"An inducible MAO-B mouse model of Parkinson\u2019s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics","volume":"125","author":"Chamoli","year":"2018","journal-title":"J. Neural Transm."},{"issue":"7148","key":"10.1016\/j.neuro.2024.06.016_bib57","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-4159.2007.05108.x","article-title":"VMAT2 and dopamine neuron loss in a primate model of Parkinson\u2019s disease","volume":"105","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2024.06.016_bib60","first-page":"1","article-title":"Parkinson\u2019s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging","volume":"15","author":"Chen","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuro.2024.06.016_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ntt.2013.04.001","article-title":"Maternal serum persistent organic pollutants in the Finnish Prenatal Study of Autism: a pilot study","volume":"38","author":"Cheslack-Postava","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib62","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","article-title":"Dopaminergic neurons","volume":"37","author":"Chinta","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"47","key":"10.1016\/j.neuro.2024.06.016_bib63","doi-asserted-by":"crossref","first-page":"12127","DOI":"10.1523\/JNEUROSCI.3158-06.2006","article-title":"Regional interaction of endoplasmic reticulum Ca2+ signals between soma and dendrites through rapid luminal Ca2+ diffusion","volume":"26","author":"Choi","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of \u03b1-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson\u2019s disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib65","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbrc.2018.12.128","article-title":"Formation of large oligomers of DOPAL-modified \u03b1-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain","volume":"509","author":"Coelho-Cerqueira","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib67","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/s41467-019-12264-9","article-title":"Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter","volume":"10","author":"Condon","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","article-title":"Oxidative DNA damage: Mechanisms, mutation, and disease","volume":"17","author":"Cooke","year":"2003","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib69","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/1570159X19666210421092725","article-title":"Do naturally occurring antioxidants protect against neurodegeneration of the dopaminergic system? A systematic revision in animal models of Parkinson\u2019s disease","volume":"20","author":"Costas","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuro.2024.06.016_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuro.2021.07.005","article-title":"In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3, 4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylacetic acid","volume":"86","author":"Crawford","year":"2021","journal-title":"NeuroToxicology"},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib71","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1021\/acs.chemrestox.1c00153","article-title":"Characterization of catecholaldehyde adducts with carnosine and L-cysteine reveals their potential as biomarkers of catecholaminergic stress","volume":"34","author":"Crawford","year":"2021","journal-title":"Chem. Res. Toxicol."},{"issue":"24","key":"10.1016\/j.neuro.2024.06.016_bib72","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1212\/WNL.0000000000010863","article-title":"Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: a metabolomic study","volume":"95","author":"Crotty","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1471-4159.1987.tb04142.x","article-title":"Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, to neuromelanin.","volume":"48","author":"D\u2019Amato","year":"1987","journal-title":"J. Neurochem."},{"issue":"4741","key":"10.1016\/j.neuro.2024.06.016_bib74","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","article-title":"Selectivity of the Parkinsonian neurotoxin MPTP: toxic metabolite MPP + binds to neuromelanin","volume":"231","author":"D\u2019Amato","year":"1986","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib75","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.1091","article-title":"Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions","volume":"16","author":"Datla","year":"2001","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/900a5247-7d03-4686-a544-5f7f64c0aac5","article-title":"Alpha-synuclein is a cellular ferrireductase","volume":"6","author":"Davies","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyab081","article-title":"Characterizing dopaminergic neuron vulnerability using genome-wide analysis","volume":"218","author":"Davis","year":"2021","journal-title":"Genetics"},{"issue":"26","key":"10.1016\/j.neuro.2024.06.016_bib79","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.1404651111","article-title":"Transcellular degradation of axonal mitochondria","volume":"111","author":"Davis","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib80","first-page":"543","article-title":"Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson\u2019s disease","volume":"22","author":"De Miranda","year":"2020","journal-title":"Environ. Sci.: Process. Impacts"},{"key":"10.1016\/j.neuro.2024.06.016_bib81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3389\/fneur.2020.00881","article-title":"Mitochondrial mechanisms of LRRK2 G2019S penetrance","volume":"11","author":"Delcambre","year":"2020","journal-title":"Front. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.neuro.2024.06.016_bib82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000101846","article-title":"Glia protects neurons against extracellular human neuromelanin","volume":"4","author":"Depboylu","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the Substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in Substantia nigra is increased in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0006-8993(96)00761-5","article-title":"Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys","volume":"738","author":"Di Monte","year":"1996","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib86","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park.\u2019s\u00a0Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib87","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1038\/ncomms13548","article-title":"Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease","volume":"7","author":"D\u00f6lle","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib89","first-page":"203","article-title":"Trichloroethylene: an invisible cause of Parkinson\u2019s disease?","volume":"13","author":"Dorsey","year":"2023","journal-title":"J. Park.\u2019s\u00a0Dis."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib90","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pneurobio.2010.06.001","article-title":"Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?","volume":"92","author":"Double","year":"2010","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib91","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharm. Rev."},{"issue":"18","key":"10.1016\/j.neuro.2024.06.016_bib92","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","article-title":"Current approaches to the treatment of Parkinson\u2019s disease","volume":"27","author":"Ellis","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.neuro.2024.06.016_bib93","doi-asserted-by":"crossref","first-page":"eabd1700","DOI":"10.1126\/sciadv.abd1700","article-title":"Tracing brain genotoxic stress in Parkinson\u2019s disease with a novel single-cell genetic sensor","volume":"8","author":"El-Saadi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuro.2024.06.016_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/S0197-0186(02)00161-4","article-title":"Residual substantia nigra neuromelanin in Parkinson\u2019s disease is cross-linked to \u2334-synuclein","author":"Fasano","year":"2003","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib95","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neurobiolaging.2005.02.015","article-title":"Evidence for specific phases in the development of human neuromelanin","volume":"27","author":"Fedorow","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib96","doi-asserted-by":"crossref","first-page":"NS20200095","DOI":"10.1042\/NS20200095","article-title":"The life cycle of voltage-gated Ca2+ channels in neurons: An update on the trafficking of neuronal calcium channels","volume":"5","author":"Ferron","year":"2021","journal-title":"Neuron Signal."},{"issue":"s1","key":"10.1016\/j.neuro.2024.06.016_bib97","first-page":"S107","article-title":"The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state?","volume":"60","author":"Fielder","year":"2017","journal-title":"J. Alzheimer\u2019s\u00a0Dis."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000000083","article-title":"Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease","volume":"82","author":"Fitzmaurice","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib99","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.1220399110","article-title":"Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease","volume":"110","author":"Fitzmaurice","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib100","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1152\/jn.00038.2009","article-title":"Endogenous calcium buffering capacity of substantia nigral dopamine neurons","volume":"102","author":"Foehring","year":"2009","journal-title":"J. Neurophysiol."},{"issue":"46","key":"10.1016\/j.neuro.2024.06.016_bib101","doi-asserted-by":"crossref","first-page":"27660","DOI":"10.1074\/jbc.M115.686584","article-title":"Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of \u03b1-synuclein with the toxic dopamine metabolite 3, 4-dihydroxyphenylacetaldehyde (DOPAL)","volume":"290","author":"Follmer","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02263482","article-title":"The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra","volume":"1","author":"Fornstedt","year":"1989","journal-title":"J. Neural Transm. - Park.\u2019s\u00a0Dis. Dement. Sect."},{"key":"10.1016\/j.neuro.2024.06.016_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01145-2","article-title":"Cell specific quantitative iron mapping on brain slices by immuno-\u00b5PIXE in healthy elderly and Parkinson\u2019s disease","volume":"9","author":"Friedrich","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"13","key":"10.1016\/j.neuro.2024.06.016_bib104","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.18-13-04861.1998","article-title":"Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter","volume":"18","author":"Fumagalli","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2024.06.016_bib105","article-title":"Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2 G2019S model of Parkinson\u2019s disease","author":"Gaertner","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib106","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease","volume":"133","author":"Garcia-Reitb\u00f6ck","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib107","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","article-title":"Midbrain dopaminergic cell loss in Parkinson\u2019s disease: computer visualization","volume":"26","author":"German","year":"1989","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"5589","key":"10.1016\/j.neuro.2024.06.016_bib108","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/265080a0","article-title":"Dopamine is a monoamine oxidase B substrate in man","volume":"265","author":"Glover","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2024.06.016_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-12-411512-5.00012-9","article-title":"Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease","volume":"68","author":"Goldstein","year":"2013","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.neuro.2024.06.016_bib110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00702-019-02106-9","article-title":"The catecholaldehyde hypothesis: Where MAO fits in","volume":"127","author":"Goldstein","year":"2020","journal-title":"J. Neural Transm."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib111","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.parkreldis.2015.07.009","article-title":"Deficient vesicular storage: a common theme in catecholaminergic neurodegeneration","volume":"21","author":"Goldstein","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jnc.13042","article-title":"Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson\u2019s disease","volume":"133","author":"Goldstein","year":"2015","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib113","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jnc.12345","article-title":"Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson\u2019s disease","volume":"126","author":"Goldstein","year":"2013","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.neuro.2024.06.016_bib114","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","article-title":"Magnesium inhibits spontaneous and iron-induced aggregation of \u03b1-synuclein","volume":"277","author":"Golts","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.neuro.2024.06.016_bib115","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1093\/hmg\/ddu395","article-title":"LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity","volume":"23","author":"Gomez-Suaga","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib116","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jnr.24592","article-title":"DNA damage and repair in Parkinson\u2019s disease: Recent advances and new opportunities.","volume":"99","author":"Gonzalez-Hunt","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib117","doi-asserted-by":"crossref","first-page":"17293","DOI":"10.1038\/s41598-020-74195-6","article-title":"Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson\u2019s disease","volume":"10","author":"Gonzalez-Hunt","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib118","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/brain\/awac445","article-title":"In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease","volume":"146","author":"Gonzalez-Sepulveda","year":"2023","journal-title":"Brain\u202f: a journal of neurology"},{"issue":"12","key":"10.1016\/j.neuro.2024.06.016_bib119","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/brain\/123.12.2423","article-title":"Brain iron deposition in Parkinson\u2019s disease imaged using the PRIME magnetic resonance sequence","volume":"123","author":"Graham","year":"2000","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib120","first-page":"644","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuro.2024.06.016_bib121","article-title":"Methamphetamine and Parkinson\u2019s disease","volume":"2013","author":"Granado","year":"2013","journal-title":"Park.\u2019s Dis."},{"issue":"37","key":"10.1016\/j.neuro.2024.06.016_bib122","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1039\/c1cc13731j","article-title":"A melanin-inspired pro-oxidant system for dopa(mine) polymerization: mimicking the natural casing process","volume":"47","author":"Greco","year":"2011","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib123","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nbd.2010.03.014","article-title":"Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents","volume":"38","author":"Greene","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib124","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-4159.2005.03019.x","article-title":"Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson\u2019s disease","volume":"93","author":"Greggio","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2024.06.016_bib125","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12640-017-9843-5","article-title":"Differential alterations in metabolism and proteolysis-related proteins in human Parkinson\u2019s disease substantia nigra","volume":"33","author":"Gr\u00fcnblatt","year":"2018","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib126","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","article-title":"Mitochondrial DNA deletions\/rearrangements in parkinson disease and related neurodegenerative disorders","volume":"61","author":"Gu","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuro.2024.06.016_bib127","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12035-009-8059-y","article-title":"Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons","volume":"39","author":"Guillot","year":"2009","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib128","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib129","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","article-title":"Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress","volume":"128","author":"Guzman","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"7324","key":"10.1016\/j.neuro.2024.06.016_bib130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.neuro.2024.06.016_bib131","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","article-title":"Robust pacemaking in substantia nigra dopaminergic neurons","volume":"29","author":"Guzman","year":"2009","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib132","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1046\/j.1471-4159.1997.69041720.x","article-title":"L-DOPA is a substrate for tyrosine hydroxylase","volume":"69","author":"Haavik","year":"1997","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib133","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.108.145631","article-title":"Mechanisms underlying methamphetamine-induced dopamine transporter complex formation","volume":"329","author":"Hadlock","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neuro.2024.06.016_bib134","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2013.07.031","article-title":"Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems","volume":"76","author":"Hall","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib136","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/ern.12.47","article-title":"Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson\u2019s disease?","volume":"12","author":"Halliday","year":"2012","journal-title":"Expert Rev. Neurother."},{"issue":"11","key":"10.1016\/j.neuro.2024.06.016_bib137","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","article-title":"\u03b1-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson\u2019s disease","volume":"128","author":"Halliday","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2024.06.016_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1219441","article-title":"Selective dopaminergic vulnerability in Parkinson\u2019s disease: new insights into the role of DAT","volume":"17","author":"Harraz","year":"2023","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib139","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms11031082","article-title":"Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson\u2019s disease","volume":"11","author":"Hasegawa","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1471-4159.2003.02008.x","article-title":"Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase","volume":"87","author":"Hasegawa","year":"2003","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson\u2019s disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib142","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib143","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1471-4159.1994.63031126.x","article-title":"Identification of catechol-protein conjugates in neostriatal slices incubated with [3H] dopamine: impact of ascorbic acid and glutathione","volume":"63","author":"Hastings","year":"1994","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib144","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.expneurol.2006.12.020","article-title":"Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system","volume":"204","author":"Hatcher","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuro.2024.06.016_bib145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2013.06.030","article-title":"Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4","volume":"65","author":"Hauser","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"7613","key":"10.1016\/j.neuro.2024.06.016_bib146","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2024.06.016_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease","volume":"10","author":"He","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib148","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.abb.2006.02.018","article-title":"Studies on genomic DNA topology and stability in brain regions of Parkinson\u2019s disease","volume":"449","author":"Hegde","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuro.2024.06.016_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1647-5","article-title":"HSV-1 triggers paracrine fibroblast growth factor response from cortical brain cells via immediate-early protein ICP0","volume":"16","author":"Hensel","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4522(91)90180-V","article-title":"Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study","volume":"40","author":"Herkenham","year":"1991","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib151","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/acs.est.8b00966","article-title":"Emissions of tetrachlorobiphenyls (PCBs 47, 51, and 68) from polymer resin on kitchen cabinets as a non-aroclor source to residential air","volume":"52","author":"Herkert","year":"2018","journal-title":"Environ. Sci. Technol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib152","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000111315","article-title":"Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem","volume":"15","author":"Herrero","year":"1993","journal-title":"Dev. Neurosci."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib153","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1289\/ehp.6912","article-title":"An unrecognized source of PCB contamination in schools and other buildings","volume":"112","author":"Herrick","year":"2004","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","volume":"7","author":"Hinkle","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"1\u20133","key":"10.1016\/j.neuro.2024.06.016_bib155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02816113","article-title":"Biochemistry of Parkinson\u2019s disease with special reference to the dopaminergic systems","volume":"9","author":"Hirsch","year":"1994","journal-title":"Mol. Neurobiol."},{"issue":"6180","key":"10.1016\/j.neuro.2024.06.016_bib156","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2024.06.016_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104842","article-title":"Non-dioxin-like polychlorinated biphenyl neurotoxic equivalents found in environmental and human samples","volume":"120","author":"Holland","year":"2021","journal-title":"Regul. Toxicol. Pharm."},{"issue":"22","key":"10.1016\/j.neuro.2024.06.016_bib158","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1093\/hmg\/ddx320","article-title":"LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson\u2019s disease","volume":"26","author":"Howlett","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib159","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/es902413k","article-title":"Inadvertent polychlorinated biphenyls in commercial paint pigments","volume":"44","author":"Hu","year":"2010","journal-title":"Environ. Sci. Technol."},{"issue":"38","key":"10.1016\/j.neuro.2024.06.016_bib160","doi-asserted-by":"crossref","first-page":"14310","DOI":"10.1021\/acs.est.3c05195","article-title":"Polyurethane foam emission samplers to identify sources of airborne polychlorinated biphenyls from glass-block windows and other room surfaces in a vermont school","volume":"57","author":"Hua","year":"2023","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib161","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.10713","article-title":"A 100\u2009% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson\u2019s disease","volume":"19","author":"Huisman","year":"2004","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib162","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.22009","article-title":"Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson\u2019s disease patients","volume":"23","author":"Huisman","year":"2008","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib163","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pharmthera.2011.11.006","article-title":"Voltage-gated calcium channels and Parkinson\u2019s disease","volume":"133","author":"Hurley","year":"2012","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncb3452","article-title":"The control of DNA repair by the cell cycle","volume":"19","author":"Hustedt","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.06.016_bib166","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib167","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/biom13010178","article-title":"Is glial dysfunction the key pathogenesis of LRRK2-linked Parkinson\u2019s disease?","volume":"13","author":"Iseki","year":"2023","journal-title":"Biomolecules"},{"issue":"40","key":"10.1016\/j.neuro.2024.06.016_bib168","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1073\/pnas.0606879103","article-title":"Encapsulation of a reactive core in neuromelanin","volume":"103","author":"Ito","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib169","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/ejn.13252","article-title":"Protection of cultured dopamine neurons from MPP+ requires a combination of neurotrophic factors","volume":"44","author":"Jaumotte","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"17","key":"10.1016\/j.neuro.2024.06.016_bib170","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.3390\/ijms231710092","article-title":"Biochemical neuroadaptations in the rat striatal dopaminergic system after prolonged exposure to methamphetamine self-administration","volume":"23","author":"Jayanthi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib171","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.29297","article-title":"LRRK2 inhibition by BIIB122 in healthy participants and patients with Parkinson\u2019s disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2024.06.016_bib172","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ceb.2014.01.003","article-title":"Sizing and shaping the nucleus: mechanisms and significance","volume":"28","author":"Jevti\u0107","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib173","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1038\/s41467-022-34555-4","article-title":"DOPAnization of tyrosine in \u03b1-synuclein by tyrosine hydroxylase leads to the formation of oligomers","volume":"13","author":"Jin","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib174","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/tx800405v","article-title":"Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate","volume":"22","author":"Jinsmaa","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.119.262246","article-title":"3, 4-Dihydroxyphenylacetaldehyde is more efficient than dopamine in oligomerizing and quinonizing \u03b1-synuclein","volume":"372","author":"Jinsmaa","year":"2020","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib176","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/jpet.118.248492","article-title":"3, 4-Dihydroxyphenylacetaldehyde-induced protein modifications and their mitigation by N-acetylcysteine","volume":"366","author":"Jinsmaa","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neuro.2024.06.016_bib177","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2014.03.016","article-title":"Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein","volume":"569","author":"Jinsmaa","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib178","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nn.4493","article-title":"Identification of diverse astrocyte populations and their malignant analogs","volume":"20","author":"John Lin","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"17","key":"10.1016\/j.neuro.2024.06.016_bib179","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20220161","article-title":"Impact of 100 LRRK2 variants linked to Parkinson\u2019s disease on kinase activity and microtubule binding","volume":"479","author":"Kalogeropulou","year":"2022","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib181","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/glia.22295","article-title":"Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer\u2019s disease mouse model","volume":"60","author":"Kamphuis","year":"2012","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib182","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1755-148X.2008.00508.x","article-title":"Retention of the cyanobacterial neurotoxin \u03b2 - N -methylamino-l-alanine in melanin and neuromelanin-containing cells \u2013 a possible link between Parkinson-dementia complex and pigmentary retinopathy","volume":"22","author":"Karlsson","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib183","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","article-title":"Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content","volume":"59","author":"Kastner","year":"1992","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib184","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/toxsci\/kfy277","article-title":"Sex-dependent effects of 2,2\u2032,3,5\u2032,6-pentachlorobiphenyl on dendritic arborization of primary mouse neurons","volume":"168","author":"Keil","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"20","key":"10.1016\/j.neuro.2024.06.016_bib185","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/ddl247","article-title":"5\u2032 and 3\u2032 region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson\u2019s disease risk: a hypothesis-generating study","volume":"15","author":"Kelada","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2024.06.016_bib186","first-page":"73","article-title":"Anatomical localisation of neuromelanin in the brains of the frog and tadpole. Ultrastructural comparison of neuromelanin with other melanins","volume":"142","author":"Kemali","year":"1985","journal-title":"J. Anat."},{"key":"10.1016\/j.neuro.2024.06.016_bib187","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67900","article-title":"Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib188","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/nyas.13140","article-title":"Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways","volume":"1394","author":"Kim","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuro.2024.06.016_bib189","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neubiorev.2017.01.013","article-title":"Brain imaging genetics in ADHD and beyond\u2013mapping pathways from gene to disorder at different levels of complexity","volume":"80","author":"Klein","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1253\/circj.70.710","article-title":"Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts","volume":"70","author":"Koda","year":"2006","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib191","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharm. Rev."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib192","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"s1","key":"10.1016\/j.neuro.2024.06.016_bib193","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2021.3283","article-title":"Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging","volume":"65","author":"Korzhevskii","year":"2021","journal-title":"Eur. J. Histochem."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib194","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-022-00289-9","article-title":"Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson\u2019s disease","volume":"8","author":"Kozina","year":"2022","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat. Genet."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib196","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(99)00238-7","article-title":"L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein","volume":"73","author":"Kuhn","year":"1999","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib197","doi-asserted-by":"crossref","first-page":"dmm049082","DOI":"10.1242\/dmm.049082","article-title":"The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson\u2019s disease","volume":"15","author":"Landau","year":"2022","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.neuro.2024.06.016_bib198","doi-asserted-by":"crossref","unstructured":"Lautenschl\u00e4ger, J., Stephens, A., Fusco, G., Strohl, F., Curry, N., Zacharopoulou, M., Michel, C., Laine, R., Nespovitaya, N., Fantham, M., 2018. Calcium binding at the C-terminus of \u03b1-synuclein modulates synaptic vesicle interaction.","DOI":"10.1038\/s41467-018-03111-4"},{"key":"10.1016\/j.neuro.2024.06.016_bib199","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuro.2020.10.005","article-title":"Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments","volume":"81","author":"Lawana","year":"2020","journal-title":"NeuroToxicology"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfz210","article-title":"Neuromelanin modulates heterocyclic aromatic amine-induced dopaminergic neurotoxicity","volume":"173","author":"Lawana","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib201","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jon.12957","article-title":"Quantitative evaluation of brain iron accumulation in different stages of Parkinson\u2019s disease","volume":"32","author":"Li","year":"2022","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.neuro.2024.06.016_bib202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12640-010-9187-x","article-title":"Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells","volume":"19","author":"Li","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuro.2024.06.016_bib203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00702-011-0753-z","article-title":"Neuromelanin enhances the toxicity of \u03b1-synuclein in SK-N-SH cells","volume":"119","author":"Li","year":"2012","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cne.20098","article-title":"Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: Human midbrain dopamine neurons","volume":"473","author":"Liang","year":"2004","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib205","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0167-17.2017","article-title":"\u03b1-Synuclein-dependent calcium entry underlies differential sensitivity of cultured SN and VTA dopaminergic neurons to a parkinsonian neurotoxin","volume":"4","author":"Lieberman","year":"2017","journal-title":"Eneuro"},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib206","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ana.23568","article-title":"Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease","volume":"71","author":"Lin","year":"2012","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib207","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0749.1987.tb00403.x","article-title":"Neuromelanin and its possible protective and destructive properties","volume":"1","author":"Lindquist","year":"1987","journal-title":"Pigment Cell Res."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(88)90002-X","article-title":"Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin","volume":"93","author":"Lindquist","year":"1988","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib209","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","article-title":"l-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson\u2019s disease?","volume":"94","author":"Lipski","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuro.2024.06.016_bib210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pharmtox-010818-021214","article-title":"The potential of L-type calcium channels as a drug target for neuroprotective therapy in Parkinson\u2019s disease","volume":"59","author":"Liss","year":"2019","journal-title":"Annu. Rev. Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib211","doi-asserted-by":"crossref","first-page":"40887","DOI":"10.1038\/srep40887","article-title":"Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson\u2019s disease","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib212","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11064-008-9599-7","article-title":"Silencing \u03b1-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells","volume":"33","author":"Liu","year":"2008","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0749.2004.00197.x","article-title":"Metal\u2013ion interactions and the structural organization of Sepia eumelanin","volume":"18","author":"Liu","year":"2005","journal-title":"Pigment Cell Res."},{"issue":"12","key":"10.1016\/j.neuro.2024.06.016_bib214","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/tx034160a","article-title":"Carnosine inhibits (E)-4-hydroxy-2-nonenal-induced protein cross-linking: structural characterization of Carnosine\u2212 HNE Adducts1","volume":"16","author":"Liu","year":"2003","journal-title":"Chem. Res. Toxicol."},{"issue":"27","key":"10.1016\/j.neuro.2024.06.016_bib215","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1073\/pnas.1402134111","article-title":"Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo","volume":"111","author":"Lohr","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib216","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/toxsci\/kfw106","article-title":"Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals","volume":"153","author":"Lohr","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib217","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2005.01.028","article-title":"DNA repair, genome stability, and aging","volume":"120","author":"Lombard","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib218","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0306-4522(84)90034-4","article-title":"Substantia nigra and ventral tegmental area projections to cortex: topography and collateralization","volume":"11","author":"Loughlin","year":"1984","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib219","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopsych.2016.05.021","article-title":"An integrative perspective on the role of dopamine in schizophrenia","volume":"81","author":"Maia","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/M20-1023","article-title":"A clinical trial of isradipine: what went wrong?","volume":"172","author":"Maiti","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001616","article-title":"MAO-B elevation in mouse brain astrocytes results in Parkinson\u2019s pathology","volume":"3","author":"Mallajosyula","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib222","first-page":"356","article-title":"Gene expression profiling of sporadic Parkinson\u2019s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70","volume":"1053","author":"Mandel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib223","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0047-6374(83)90074-X","article-title":"Possible role of neuromelanin in the pathogenesis of Parkinson\u2019s disease","volume":"21","author":"Mann","year":"1983","journal-title":"Mech. Ageing Dev."},{"issue":"14","key":"10.1016\/j.neuro.2024.06.016_bib224","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1021\/acs.est.7b01910","article-title":"Airborne PCBs and OH-PCBs inside and outside urban and rural US schools","volume":"51","author":"Marek","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.neuro.2024.06.016_bib225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","article-title":"Recent advances in the genetics of Parkinson\u2019s disease","volume":"12","author":"Martin","year":"2011","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"16_part_2","key":"10.1016\/j.neuro.2024.06.016_bib226","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease: a potential biomarker of disease status","volume":"70","author":"Martin","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib227","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41531-023-00485-1","article-title":"DOPAL initiates \u03b1Synuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson\u2019s disease","volume":"9","author":"Masato","year":"2023","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"key":"10.1016\/j.neuro.2024.06.016_bib228","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","article-title":"Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits","volume":"74","author":"Masoud","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib229","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson\u2019s disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single Nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib231","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(87)90213-8","article-title":"Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodents","volume":"83","author":"Melamed","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib232","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuro.2011.03.013","article-title":"Inhibition and covalent modification of tyrosine hydroxylase by 3, 4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite","volume":"32","author":"Mexas","year":"2011","journal-title":"Neurotoxicology"},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib233","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib234","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41419-018-0848-7","article-title":"Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson\u2019s disease","volume":"9","author":"Milanese","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/toxsci\/kfm095","article-title":"Manganese induces oxidative impairment in cultured rat astrocytes","volume":"98","author":"Milatovic","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"24","key":"10.1016\/j.neuro.2024.06.016_bib236","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2024.06.016_bib237","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.580634","article-title":"The convergence of alpha-synuclein, mitochondrial, and lysosomal pathways in vulnerability of midbrain dopaminergic neurons in Parkinson\u2019s disease","volume":"8","author":"Minakaki","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.neuro.2024.06.016_bib238","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1042\/BCJ20180248","article-title":"The Parkinson\u2019s disease VPS35 [D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human","volume":"475","author":"Mir","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuro.2024.06.016_bib239","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.envint.2015.05.004","article-title":"Yusho and its latest findings\u2014a review in studies conducted by the Yusho Group","volume":"82","author":"Mitoma","year":"2015","journal-title":"Environ. Int."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib240","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-7-26","article-title":"A molecular signature in blood identifies early Parkinson\u2019s disease","volume":"7","author":"Molochnikov","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib242","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.chemrestox.1c00262","article-title":"A catecholaldehyde metabolite of norepinephrine induces myofibroblast activation and toxicity via the receptor for advanced glycation endproducts: mitigating role of l-carnosine","volume":"34","author":"Monroe","year":"2021","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib243","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and \u03b1-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2024.06.016_bib244","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81407","article-title":"CaV1 and CaV2 calcium channels mediate the release of distinct pools of synaptic vesicles","volume":"12","author":"Mueller","year":"2023","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundi\u00f1ano","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib246","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41531-023-00624-8","article-title":"A potential patient stratification biomarker for Parkinson\u00b4 s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells","volume":"10","author":"Naaldijk","year":"2024","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib247","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.3390\/ijms23084176","article-title":"Neuromelanin in Parkinson\u2019s disease: tyrosine hydroxylase and tyrosinase","volume":"23","author":"Nagatsu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib248","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-8993(95)00082-2","article-title":"Methyl-\u03b2-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats","volume":"675","author":"Neafsey","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2024.06.016_bib249","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00726-018-2647-y","article-title":"Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium","volume":"51","author":"Nelson","year":"2019","journal-title":"Amino Acids"},{"issue":"25","key":"10.1016\/j.neuro.2024.06.016_bib250","doi-asserted-by":"crossref","first-page":"22680","DOI":"10.1074\/jbc.M101181200","article-title":"Ca2+ binding to \u03b1-synuclein regulates ligand binding and oligomerization","volume":"276","author":"Nielsen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib251","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/ijms22031383","article-title":"Urinary levels of the acrolein conjugates of carnosine are associated with cardiovascular disease risk","volume":"22","author":"O\u2019Toole","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib252","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0197-0186(96)00150-7","article-title":"Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson\u2019s disease","volume":"31","author":"Offen","year":"1997","journal-title":"Neurochem Int"},{"issue":"11","key":"10.1016\/j.neuro.2024.06.016_bib253","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.stemcr.2021.09.014","article-title":"Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson\u2019s disease","volume":"16","author":"Oosterveen","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"1)","key":"10.1016\/j.neuro.2024.06.016_bib254","first-page":"13","article-title":"overview of common movement disorders","volume":"16","author":"Ostrem","year":"2010","journal-title":"Continuum: Lifelong Learn. Neurol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.25510","article-title":"Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers","volume":"86","author":"Ouzren","year":"2019","journal-title":"Ann. Neurol."},{"issue":"18","key":"10.1016\/j.neuro.2024.06.016_bib256","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"issue":"s2","key":"10.1016\/j.neuro.2024.06.016_bib257","first-page":"211","article-title":"Role of advanced glycation on aggregation and DNA binding properties of \u03b1-synuclein","volume":"24","author":"Padmaraju","year":"2011","journal-title":"J. Alzheimer\u2019s\u00a0Dis."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045183","article-title":"The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib259","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","article-title":"LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson\u2019s disease","volume":"11","author":"Pang","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"12","key":"10.1016\/j.neuro.2024.06.016_bib260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015251","article-title":"The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis","volume":"5","author":"Panneton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2024.06.016_bib261","doi-asserted-by":"crossref","unstructured":"Pena, N., Gonzalez-Hunt, C.P., Qi, R., Barlow, C., Shanks, N.F., Carlisle, H.J.,\u00a0Sanders, L.H., 2022. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage. bioRxiv, pp. 2022\u201311.","DOI":"10.1101\/2022.11.30.517979"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib262","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41531-024-00660-y","article-title":"G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage","volume":"10","author":"Pena","year":"2024","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"8","key":"10.1016\/j.neuro.2024.06.016_bib263","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for \u03b1-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib264","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41380-018-0226-y","article-title":"Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments","volume":"25","author":"Petrelli","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"24","key":"10.1016\/j.neuro.2024.06.016_bib265","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1523\/JNEUROSCI.5456-13.2014","article-title":"Is Parkinson\u2019s disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum","volume":"34","author":"Pifl","year":"2014","journal-title":"J. Neurosci."},{"issue":"20","key":"10.1016\/j.neuro.2024.06.016_bib266","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1113\/JP270672","article-title":"Cav1. 3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders","volume":"594","author":"Pinggera","year":"2016","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib267","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-023-00608-8","article-title":"Analysis of rare Parkinson\u2019s disease variants in millions of people","volume":"10","author":"Pitz","year":"2024","journal-title":"Npj Park.\u2019s\u00a0Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib268","doi-asserted-by":"crossref","first-page":"40699","DOI":"10.1038\/srep40699","article-title":"DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function","volume":"7","author":"Plotegher","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuro.2024.06.016_bib269","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2019.09.015","article-title":"Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson\u2019s disease","volume":"48","author":"Podlesniy","year":"2019","journal-title":"EBioMedicine"},{"issue":"7949","key":"10.1016\/j.neuro.2024.06.016_bib270","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-023-05711-7","article-title":"A NPAS4\u2013NuA4 complex couples synaptic activity to DNA repair","volume":"614","author":"Pollina","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02942-8","article-title":"Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson\u2019s model","volume":"11","author":"Pradhan","year":"2020","journal-title":"Cell Death Dis."},{"issue":"711","key":"10.1016\/j.neuro.2024.06.016_bib272","doi-asserted-by":"crossref","first-page":"eabo1557","DOI":"10.1126\/scitranslmed.abo1557","article-title":"A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease","volume":"15","author":"Qi","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib273","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jtemb.2013.08.001","article-title":"Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes","volume":"28","author":"Ramos","year":"2014","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib274","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuro.2007.03.001","article-title":"Manganese induces cell swelling in cultured astrocytes","volume":"28","author":"Rao","year":"2007","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib275","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cell.2007.08.043","article-title":"Defective DNA repair and neurodegenerative disease","volume":"130","author":"Rass","year":"2007","journal-title":"Cell"},{"issue":"49","key":"10.1016\/j.neuro.2024.06.016_bib276","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1523\/JNEUROSCI.2250-11.2011","article-title":"Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen\/nitrogen species","volume":"31","author":"Rathnasamy","year":"2011","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib277","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/tx9000557","article-title":"Protein reactivity of 3, 4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol","volume":"22","author":"Rees","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib278","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1096\/fj.06-5864fje","article-title":"Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson\u2019s disease","volume":"20","author":"Richardson","year":"2006","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib279","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1523\/JNEUROSCI.19-09-03519.1999","article-title":"Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase","volume":"19","author":"Rios","year":"1999","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib280","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1289\/ehp.0800277","article-title":"Dopamine transporter genetic variants and pesticides in Parkinson\u2019s disease","volume":"117","author":"Ritz","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2024.06.016_bib281","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s40572-016-0083-2","article-title":"Of pesticides and men: a California story of genes and environment in Parkinson\u2019s disease","volume":"3","author":"Ritz","year":"2016","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.neuro.2024.06.016_bib282","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.06.016_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104626","article-title":"LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson\u2019s disease","volume":"134","author":"Rocha","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib284","doi-asserted-by":"crossref","DOI":"10.1289\/EHP553","article-title":"Prenatal and postnatal PCB-153 and p, p\u2032-DDE exposures and behavior scores at 5\u20139 years of age among children in Greenland and Ukraine","volume":"125","author":"Rosenquist","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2024.06.016_bib285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1483-7","article-title":"Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype","volume":"16","author":"Rudyk","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib286","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/s41598-018-23827-z","article-title":"Locus coeruleus complex of the family Delphinidae","volume":"8","author":"Sacchini","year":"2018","journal-title":"Sci. Rep."},{"issue":"47","key":"10.1016\/j.neuro.2024.06.016_bib287","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib288","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/mds.28189","article-title":"Nonsteroidal anti-inflammatory use and LRRK2 Parkinson\u2019s disease penetrance","volume":"35","author":"San Luciano","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2024.06.016_bib289","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuro.2024.06.016_bib290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","article-title":"LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction","volume":"62","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.06.016_bib291","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","article-title":"Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson\u2019s disease","volume":"70","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib292","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/toxsci\/kfx086","article-title":"Editor\u2019s highlight: base excision repair variants and pesticide exposure increase Parkinson\u2019s disease risk.","volume":"158","author":"Sanders","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib293","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.mehy.2012.05.015","article-title":"Disruption of spine homeostasis causes dopaminergic compensatory up-regulation, resulting in schizophrenia","volume":"79","author":"Sato","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib294","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1289\/ehp.5461","article-title":"Effects of PCB exposure on neuropsychological function in children","volume":"111","author":"Schantz","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuro.2024.06.016_bib295","doi-asserted-by":"crossref","unstructured":"Seegal, R.F., 1994. Decreases in dopamine concentrations in adult, non-human pr!mate brain persist following removal from polychlorinated biphenyls.","DOI":"10.1016\/0300-483X(94)90054-X"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib296","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/taap.1997.8226","article-title":"Effects of in utero and lactational exposure of the laboratory rat to 2,4,2\u2032,4\u2032- and 3,4,3\u2032,4\u2032-tetrachlorobiphenyl on dopamine function","volume":"146","author":"Seegal","year":"1997","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib297","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0041-008X(90)90113-9","article-title":"Lightly chlorinated ortho-substituted PCB congeners decrease dopamine in nonhuman primate brain and in tissue culture","volume":"106","author":"Seegal","year":"1990","journal-title":"Toxicol. Appl. Pharm."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib298","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.celrep.2016.04.071","article-title":"Inefficient DNA repair is an aging-related modifier of Parkinson\u2019s disease","volume":"15","author":"Sepe","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib299","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/ijms23052484","article-title":"The complex mechanisms by which neurons die following DNA damage in neurodegenerative diseases","volume":"23","author":"Shadfar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib300","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-023-00350-4","article-title":"Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases","volume":"12","author":"Shadfar","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"10\u201311","key":"10.1016\/j.neuro.2024.06.016_bib301","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00702-004-0211-2","article-title":"Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells","volume":"111","author":"Shamoto-Nagai","year":"2004","journal-title":"J. Neural Transm."},{"issue":"164","key":"10.1016\/j.neuro.2024.06.016_bib302","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"23","key":"10.1016\/j.neuro.2024.06.016_bib303","doi-asserted-by":"crossref","first-page":"eabm4560","DOI":"10.1126\/sciadv.abm4560","article-title":"Cav1. 3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons","volume":"8","author":"Shin","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuro.2024.06.016_bib304","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67464","article-title":"\u03922-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity","volume":"11","author":"Siller","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","article-title":"Neuronal voltage-gated calcium channels: Structure, function, and dysfunction","volume":"82","author":"Simms","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.neuro.2024.06.016_bib306","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/ar100079y","article-title":"The Red and the Black","volume":"43","author":"Simon","year":"2010","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib308","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine versus placebo in early Parkinson disease a randomized trial","volume":"172","author":"Simuni","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib309","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0308-8146(99)00195-8","article-title":"Effects of heating conditions and additives on the formation of heterocyclic amines with reference to amino-carbolines in a meat juice model system","volume":"68","author":"Skog","year":"2000","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0773.1990.tb00743.x","article-title":"Distribution of 1-( 3H)methyl-4-phenyl-1,2,3,6-tetrahydropyridine (3 H-MPTP) in the frog: uptake in neuromelanin","volume":"66","author":"Sokolowski","year":"1990","journal-title":"Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib311","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/19336950.2020.1807851","article-title":"Loss of Cav1. 2 channels impairs hippocampal theta burst stimulation-induced long-term potentiation","volume":"14","author":"Sridharan","year":"2020","journal-title":"Channels"},{"key":"10.1016\/j.neuro.2024.06.016_bib312","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib313","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-003-0080-0","article-title":"Long-term retention of neurotoxic B-carbolines in brain neuromelanin","volume":"111","author":"Stergren","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2024.06.016_bib314","doi-asserted-by":"crossref","unstructured":"Striessnig, J., Koschak, A., Sinnegger-Brauns, M., Hetzenauer, A., Nguyen, N., Busquet, P., Pelster, G., Singewald, N., 2006. Role of voltage-gated L-type Ca2+ channel isoforms for brain function.","DOI":"10.1042\/BST0340903"},{"issue":"22","key":"10.1016\/j.neuro.2024.06.016_bib315","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib316","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-4159.2008.05385.x","article-title":"Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease","volume":"106","author":"Sulzer","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib317","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033289","article-title":"Intraneuronal dopamine-quinone synthesis: a review","volume":"1","author":"Sulzer","year":"1999","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib318","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009290","article-title":"Physiological phenotype and vulnerability in Parkinson\u2019s disease","volume":"2","author":"Surmeier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib319","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.28850","article-title":"Re-analysis of the STEADY-PD II trial\u2014evidence for slowing the progression of Parkinson\u2019s disease","volume":"37","author":"Surmeier","year":"2022","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.neuro.2024.06.016_bib320","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","article-title":"Calcium, bioenergetics, and neuronal vulnerability in Parkinson\u2019s disease","volume":"288","author":"Surmeier","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuro.2024.06.016_bib321","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","article-title":"T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease","volume":"11","author":"Tabata","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuro.2024.06.016_bib322","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00210-002-0640-0","article-title":"Astroglial dopamine transport is mediated by norepinephrine transporter","volume":"366","author":"Takeda","year":"2002","journal-title":"Naunyn-Schmiede.\u2019s\u00a0Arch. Pharm."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib323","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1111\/ejn.15437","article-title":"Neonatal 6-OHDA lesion of the SNc induces striatal compensatory sprouting from surviving SNc dopaminergic neurons without VTA contribution","volume":"54","author":"Tanguay","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib324","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1101\/gad.229518.113","article-title":"Astrocytes engage unique molecular programs to engulf pruned neuronal debris from distinct subsets of neurons","volume":"28","author":"Tasdemir-Yilmaz","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuro.2024.06.016_bib326","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2013.08.033","article-title":"Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus","volume":"76","author":"Taylor","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2024.06.016_bib327","article-title":"VMAT2-deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson\u2019s disease","volume":"2011","author":"Taylor","year":"2011","journal-title":"Park.\u2019s\u00a0Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib328","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41531-023-00544-7","article-title":"Perspective on the current state of the LRRK2 field","volume":"9","author":"Taymans","year":"2023","journal-title":"Npj Park.\u2019s Dis."},{"issue":"24","key":"10.1016\/j.neuro.2024.06.016_bib329","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1074\/jbc.M709014200","article-title":"The reaction of \u03b1-synuclein with tyrosinase","volume":"283","author":"Tessari","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2024.06.016_bib330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-328X(97)00301-X","article-title":"New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain","volume":"53","author":"Tief","year":"1998","journal-title":"Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib331","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib332","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41419-017-0221-2","article-title":"Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson\u2019s disease","volume":"9","author":"Tozzi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib333","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1469-7610.2007.01851.x","article-title":"Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD","volume":"49","author":"Tripp","year":"2008","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neuro.2024.06.016_bib334","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","article-title":"Inflammation in Parkinson\u2019s disease","author":"Tufekci","year":"2012"},{"key":"10.1016\/j.neuro.2024.06.016_bib335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2741\/4375","article-title":"Mitochondrial DNA damage induced autophagy, cell death, and disease","volume":"21","author":"Van Houten","year":"2016","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib336","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2017.08.067","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3, 4-dihydroxyphenylacetaldehyde","volume":"492","author":"Vanle","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib337","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/acn3.51300","article-title":"Isradipine plasma pharmacokinetics and exposure\u2013response in early Parkinson\u2019s disease","volume":"8","author":"Venuto","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuro.2024.06.016_bib338","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fnagi.2019.00382","article-title":"CaV1. 3 L-type calcium channels increase the vulnerability of substantia nigra dopaminergic neurons in MPTP mouse model of Parkinson\u2019s disease","volume":"11","author":"Verma","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib339","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12974-014-0228-x","article-title":"Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism","volume":"12","author":"Viceconte","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neuro.2024.06.016_bib340","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79771","article-title":"A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation","volume":"11","author":"Vides","year":"2022","journal-title":"Elife"},{"issue":"46","key":"10.1016\/j.neuro.2024.06.016_bib341","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110094118","article-title":"Regulation of neuronal excitation\u2013transcription coupling by Kv2. 1-induced clustering of somatic L-type Ca2+ channels at ER-PM junctions","volume":"118","author":"Vierra","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.neuro.2024.06.016_bib342","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.27776","article-title":"Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease","volume":"34","author":"Vila","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib343","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib344","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1471-4159.2003.01917.x","article-title":"The structure of neuromelanin as studied by chemical degradative methods","volume":"86","author":"Wakamatsu","year":"2003","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib345","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.3390\/ijms24076313","article-title":"DNA damage-mediated neurotoxicity in Parkinson\u2019s disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib346","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1038\/s41598-021-91943-4","article-title":"Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib347","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/acs.joc.9b01948","article-title":"Synthetic evidence of the Amadori-type alkylation of biogenic amines by the neurotoxic metabolite dopegal","volume":"85","author":"Wanner","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.neuro.2024.06.016_bib348","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51071","article-title":"LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis","volume":"9","author":"Weindel","year":"2020","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib349","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154217","article-title":"Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease","volume":"23","author":"Welch","year":"2022","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib350","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1074\/jbc.M117.808402","article-title":"RAD52 is required for RNA-templated recombination repair in post-mitotic neurons","volume":"293","author":"Welty","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.neuro.2024.06.016_bib351","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1002\/anie.201600277","article-title":"Toxic dopamine metabolite DOPAL forms an unexpected dicatechol pyrrole adduct with lysines of \u03b1-synuclein","volume":"55","author":"Werner-Allen","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.neuro.2024.06.016_bib352","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1021\/acs.biochem.7b01164","article-title":"Isoindole linkages provide a pathway for DOPAL-mediated cross-linking of \u03b1-synuclein","volume":"57","author":"Werner-Allen","year":"2018","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib353","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"4722","key":"10.1016\/j.neuro.2024.06.016_bib354","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.3875898","article-title":"Distinct monoamine oxidase A and B populations in primate brain","volume":"230","author":"Westlund","year":"1985","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.02-0314fje","article-title":"Activation of microglia by human neuromelanin is NF-\u03baB-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease","volume":"17","author":"Wilms","year":"2003","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib356","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib357","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.acthis.2009.07.007","article-title":"Phosphorylation of \u03b1-synuclein upregulates tyrosine hydroxylase activity in MN9D cells","volume":"113","author":"Wu","year":"2011","journal-title":"Acta Histochem."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib358","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s42003-022-04136-8","article-title":"R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations","volume":"5","author":"Xenias","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib359","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(96)00308-7","article-title":"Tyrosine mRNA is expressed in human substantia nigra","volume":"45","author":"Xu","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuro.2024.06.016_bib360","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00702-011-0636-3","article-title":"Increase expression of \u03b1-synuclein in aged human brain associated with neuromelanin accumulation","volume":"118","author":"Xuan","year":"2011","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib361","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1073\/pnas.94.2.514","article-title":"Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress","volume":"94","author":"Yakes","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2024.06.016_bib362","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","article-title":"Relative sparing in Parkinson\u2019s disease of substantia nigra dopamine neurons containing calbindin-D28K","volume":"526","author":"Yamada","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2024.06.016_bib363","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62852","article-title":"DNA damage\u2014how and why we age?","volume":"10","author":"Yousefzadeh","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib364","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","article-title":"LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients.","volume":"10","author":"Ysselstein","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuro.2024.06.016_bib365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2015.04.019","article-title":"In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra","volume":"271","author":"Yu","year":"2015","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuro.2024.06.016_bib366","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharm. Rev."},{"issue":"45","key":"10.1016\/j.neuro.2024.06.016_bib367","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.0808768105","article-title":"New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals","volume":"105","author":"Zecca","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib368","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","article-title":"The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease","volume":"510","author":"Zecca","year":"2002","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.neuro.2024.06.016_bib369","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuro.2024.06.016_bib370","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.1994.62031097.x","article-title":"Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain","volume":"62","author":"Zecca","year":"1994","journal-title":"J. Neurochem."},{"issue":"26","key":"10.1016\/j.neuro.2024.06.016_bib371","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0403495101","article-title":"The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging","volume":"101","author":"Zecca","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib372","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","article-title":"Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson\u2019s disease","volume":"116","author":"Zecca","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib373","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/E591","article-title":"Human neuromelanin an endogenous microglial activator for dopaminergic neuron death","volume":"E5","author":"Zhang","year":"2013","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib374","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00395-015-0523-4","article-title":"Persistent increases in Ca2+ influx through Cav1.2 shortens action potential and causes Ca2+ overload-induced afterdepolarizations and arrhythmias","volume":"111","author":"Zhang","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.neuro.2024.06.016_bib376","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1172\/JCI64502","article-title":"shRNA targeting \u03b1-synuclein prevents neurodegeneration in a Parkinson\u2019s disease model","volume":"125","author":"Zharikov","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuro.2024.06.016_bib377","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuro.2024.06.016_bib378","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41531-018-0050-8","article-title":"Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson\u2019s disease","volume":"4","author":"Zucca","year":"2018","journal-title":"Npj Park.\u2019s\u00a0Dis."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2400072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2400072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T20:15:06Z","timestamp":1722197706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X2400072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":378,"alternative-id":["S0161813X2400072X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2024.06.016","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2024.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}